dihexa factory CAS No.1401708-83-5,Dihexa Suppliers dihexa clinical trials status Dihexa

S.ZahraF

| Target Concentration | BAC Water to Add | Dose per 10 units on syringe | |---------------------|-----------------|------------------------------| | 8mg/ml | 3.0ml | 0.8mg | | 12mg/ml | 2.0ml | 1.2mg | | 6mg/ml | 4.0ml | 0.6mg | **Best for:** Patients on 4-8mg weekly doses (therapeutic range)

Understanding this temporal relationship could be key in determining the true nature of their association, providing crucial insights into the pathogenesis of CU

At this concentration, the vial supports repeated withdrawals for up to 28 days under proper aseptic handling

Injectable B12 delivers the vitamin directly into the bloodstream, allowing for immediate absorption